logo
episode-header-image
Feb 2024
34m 59s

RSV and Vaccine Hesitancy

Clevleand Clinic Respiratory Institute
About this episode
Dr. Michaela Gack explains her research on emerging respiratory viruses and vector-borne pathogens. She discusses the recent advancements in RSV vaccine development while addressing the challenges in RSV epidemiology, vaccination strategies and the importance of education, messaging, and novel approaches in antiviral treatment. 
Up next
Jul 28
Risk Assessment & Mitigation of Perioperative Pulmonary Complications
In this episode of Respiratory Exchange, Dr. Preethi Patel joins Dr. Daniel Culver to discuss preoperative pulmonary evaluation and its critical role in surgical outcomes. They explore why pulmonary complications are more common than cardiac events, key patient and procedural ris ... Show More
23m 40s
Jul 14
Recognizing and Managing Telomere Biology Disorders
Telomere biology disorders are increasingly recognized as drivers of pulmonary fibrosis, bone marrow failure, liver disease, and other age-related conditions. In this episode of Respiratory Exchange, Dr. Daniel Culver is joined by Dr. Brian Southern and Dr. Hetty Carraway to expl ... Show More
35m 27s
May 29
Highlights from the 2026 ATS Conference
Host Daniel Culver, DO, is joined by Cleveland Clinic pulmonologists Rachel Scheraga, MD, and Vickram Tejwani, MD, for a recap of the 2026 American Thoracic Society Conference (ATS). They discuss key scientific and clinical highlights, including support for early-career investiga ... Show More
26m 49s
Recommended Episodes
Mar 2023
RSV Vaccines Are Coming At Last: Your Health, Quickly, Episode 2
A vaccine pioneer tells us that shots to protect against RSV—a dangerous virus for babies and older people—are finally nearing approval. Learn more about your ad choices. Visit megaphone.fm/adchoices 
10m 22s
Nov 2022
A vaccine for RSV
A respiratory virus called RSV has a lot of kids in critical condition and hospitals overwhelmed. Vox public health reporter and epidemiologist Keren Landman explains newfound hope for a vaccine. This episode was produced by Victoria Chamberlin, edited by Matt Collette, fact-chec ... Show More
26m 6s
Sep 2023
171 - Two Vax's and a MAB: What's New in RSV Prevention
In this episode, we briefly review RSV (respiratory syncytial virus) infections and focus on new data supporting the use of two different RSV vaccines (Abrysvo and Arvexy) in preventing RSV infections in older adults and in pregnant women. Key Concepts RSV is a contagious respira ... Show More
42m 31s
Feb 2022
Covid boosters, Vaccine hesitancy in pregnancy, Group B strep
Will we need boosters forever? It’s the question you wanted us to tackle so we’re joined by Prof Beate Kampmann, the Director of The Vaccine Centre at the London School of Hygiene and Tropical Medicine, in the search for answers. Then we explore why so few pregnant women are taki ... Show More
28m 2s
Oct 2015
Maladies and mice. Pre-clinical vaccine development
Approaches used to target particularly tricky diseases to treat, such as malaria, HIV, Flu and TB. Whilst many of the world’s major diseases can be targeted by vaccines there is a drastic need for new or improved vaccines against a number of the most deadly including HIV, malaria ... Show More
12m 34s
Dec 2020
Vaccine hesitancy, the next pandemic hurdle
As the Pfizer-BioNTech vaccine rolls out across the country, and other vaccines await imminent regulatory approval, many public health experts are focusing on the issue of vaccine hesitancy. Canada's Chief Public Health Officer Dr. Theresa Tam has spoken out about the "moveable m ... Show More
31m 47s
Aug 2024
Respiratory syncytial virus (RSV)
Sponsored by Pfizer Limited. Pfizer has had no involvement in the editorial component of this educational material. Editorial and content decisions were made solely by the RCGP.Respiratory syncytial virus (RSV) is an RNA virus which causes respiratory infections; the most signifi ... Show More
10m 2s
Mar 2021
In the Eye of the Pandemic
How virologist Dr. Nada Melhem, from AUB's Faculty of Health Sciences, has been tackling the challenges of COVID-19 and whether she thinks we’ll have a vaccine soon to begin a return to normal life.Interview recorded in September 2020 before phase three trails of COVID-19 vaccine ... Show More
20m 28s